2025-08-21 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the data you provided, formatted as a concise report in English:

**Report: UnitedHealth Group Inc (UNH) Analysis**

**1. Performance Overview**

*   **Ticker:** UNH
*   **Company Description:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and services.
*   **Cumulative Return (UNH):** -24.76%
*   **Cumulative Return (VOO):** 37.28%
*   **Relative Performance:** UNH is significantly underperforming the S&P 500 (VOO) with a gap of -82.4%. The relative divergence indicates that UNH is positioned at the 12.1th percentile of its historical performance relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta    | Cap(B) |
|------------|---------|---------|---------|---------|--------|
| 2015-2017  | 0.0%    | 0.0%    | 0.0%    | 1.0     | 199.7  |
| 2016-2018  | 0.0%    | 0.0%    | 0.0%    | 1.0     | 225.6  |
| 2017-2019  | 0.0%    | 0.0%    | 0.0%    | 1.0     | 266.2  |
| 2018-2020  | 0.0%    | 0.0%    | 0.0%    | 1.0     | 317.6  |
| 2019-2021  | 7.0%    | 0.0%    | 7.0%    | -0.2    | 454.8  |
| 2020-2022  | 5.0%    | 66.6%   | 16.0%   | -0.5    | 480.2  |
| 2021-2023  | 6.0%    | 67.7%   | -4.0%   | -0.2    | 476.8  |
| 2022-2024  | -6.0%   | 68.3%   | -35.0%  | -0.2    | 458.1  |
| 2023-2025  | -28.0%  | 75.6%   | -72.0%  | -0.1    | 271.6  |

*   **Analysis:**  The historical data shows a concerning trend.  While earlier periods had positive performance, the most recent periods (2021-2025) show negative CAGR, significant MDD increases, and strongly negative Alpha values.  The Beta values are generally low or negative, indicating a less direct correlation with the market, or even inverse.  The market cap is showing decreasing trend in recent years, which may cause concern.

**2. Recent Price Action**

*   **Last Price:** 299.84
*   **Previous Close:** 304.24
*   **Change:** -1.45
*   **5-Day Moving Average:** 297.614
*   **20-Day Moving Average:** 268.167
*   **60-Day Moving Average:** 290.745

*   **Analysis:** The price is slightly down from the previous close. The price is above all moving averages, which may indicate a positive trend.

**3. Technical Indicators & Market Risk**

*   **Market Risk Indicator (MRI):** 0.3316 (Low Risk)
*   **RSI:** 74.07 (Approaching Overbought)
*   **PPO:** 2.84
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.33)
*   **20-Day Relative Divergence Change:** +11.4 (Short-Term Increase)
*   **Expected Return:** 69.0% (Long-Term, vs. S&P 500)

*   **Analysis:**
    *   The MRI indicates low market risk.
    *   The RSI is approaching overbought territory, suggesting potential for a pullback.
    *   The PPO indicates a positive trend but needs to be considered with the RSI.
    *   The hybrid signal is a buy signal.
    *   The increased relative divergence suggests a short-term positive trend relative to the S&P 500.
    *   The high expected return suggests long-term potential outperformance, but this contradicts with recent price action

**4. Recent News & Events**

*   **Summary:** Recent news indicates volatility and analyst discussions regarding UNH's performance in the context of industry trends and global economic factors. Investors are advised to monitor news and company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2025-08-11 | 3.76 | 111.62 B$  |
| 2025-05-07 | 6.9  | 109.58 B$  |
| 2024-11-04 | 6.56 | 100.82 B$  |
| 2024-08-09 | 4.58 | 98.86 B$  |
| 2025-08-11 | 4.58 | 98.86 B$  |

*   **Analysis:** Revenue has been generally increasing. It's important to understand why the EPS was lower in the most recent quarter compared to the previous one, despite higher revenue.

**6. Financial Information**

*   **Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $111.62B  | 17.93%        |
| 2025-03-31 | $109.58B  | 21.70%        |
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |

*   **Capital and Profitability:**

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2025-06-30 | $94.72B   | 3.60%   |
| 2025-03-31 | $95.04B   | 6.62%   |
| 2024-12-31 | $92.66B   | 5.98%   |
| 2024-09-30 | $94.53B   | 6.41%   |
| 2024-06-30 | $89.36B   | 4.72%   |

*   **Analysis:** Revenue has been growing, but the profit margin saw a decrease in the most recent quarter. ROE also decreased significantly.

**7. Overall Assessment**

UNH is currently underperforming the S&P 500 significantly. Recent price action shows a small decrease and is trading above the moving averages, indicating potential support. The RSI is nearing overbought, suggesting caution. The MRI indicates low market risk.

The earnings data shows growing revenue, but declining profit margins and ROE in the latest quarter are concerning. The high expected return may be unrealistic given the recent underperformance.

Recent news suggests increased volatility and analyst scrutiny.

**Recommendation:**

A cautious approach is warranted. While the hybrid signal suggests a buy, the technical indicators, declining profitability, and underperformance compared to the S&P 500 suggest potential risks. Further investigation into the reasons for the declining profit margins and ROE is recommended before making any investment decisions. Investors should closely monitor upcoming news and earnings reports.
